o-toluidine


  • 中文别名:邻甲苯胺
  • 中文释义:邻甲苯胺;2-甲基苯胺;邻甲基苯胺;2-氨基甲苯;邻氨基甲苯
  • 英文别名:o-toluidine;
    o-Toluidine;
    o-Toluide;
    o-Toluidin;
    0-Toluidine;
    2-Toluidine;
    2-methylphenylamine;
    ortho-methyl aniline;
    2-methyl-aniline;
    o-Toluidyna;
    2-methylbenzenamine;
    toluidines;
    1-amino-2-methylbenzene 
  • CAS No.:95-53-4
  • 分子式:

    C7H9N

  • 分子量:107.15300
  • 精确分子量:107.07300
  • PSA:26.02000
  • MDL:MFCD00007730
  • 分子结构式:

物化性质

外观与性状:
淡黄色至淡琥珀色液体
密度:
1.004 g/mL at 25 °C(lit.)
熔点:
-23 °C
沸点:
199-200 °C(lit.)
闪点:
185 °F
水溶解性:
1.5 g/100 mL (25 ºC)
折射率:
n20/D 1.572(lit.)
蒸汽密度:
3.7 (vs air)
存储条件/存储方法:
库房通风低温干燥,与酸类和氧化剂分开存放
稳定性相关:

1.化学性质:与苯胺相似。与酸生成盐。与亚硝酸发生重氮化反应,生成重氮化合物。与醇、卤代烃、烯烃等反应,生成N-烷基化合物。在芳核上能发生烷基化、卤化、磺化、硝化、亚硝化等反应,发生在氨基的邻位和对位。与粉末状硫加热到200 ℃生成噻唑环。在稀硫酸中用铬酸、二氧化锰氧化时,根据条件不同,生成对甲苯醌、2,2'-二甲基偶氮苯或邻硝基甲苯等。用锂还原时得到2-甲基环己胺。

2.稳定性[22] 稳定

3.禁配物[23] 强氧化剂、酸类、酰基氯、酸酐、氯仿

4.避免接触的条件[24] 光照、受热

5.聚合危害[25] 不聚合

6.分解产物[26]

其它信息:

1.性状:无色或淡黄色油状液体[1]

2.熔点(℃):-16.3[2]

3.沸点(℃):200.3[3]

4.相对密度(水=1):1.008[4]

5.相对蒸气密度(空气=1):3.69[5]

6.饱和蒸气压(kPa):0.0346(25℃)[6]

7.燃烧热(kJ/mol):-4054.3[7]

8.临界压力(MPa):3.75[8]

9.辛醇/水分配系数:1.32[9]

10.闪点(℃):85(CC)[10]

11.引燃温度(℃):481.67[11]

12.爆炸上限(%):7.6[12]

13.爆炸下限(%):1.5[13]

14.溶解性:微溶于水,溶于乙醇、乙醚、稀酸。[14]

15.黏度(mPa·s,15ºC):5.195

16.黏度(mPa·s,25ºC):3.390

17.蒸发热(KJ/kg,b.p.):416.4

18.熔化热(KJ/kg):70.3

19.生成热(KJ/mol):-2.76

20.燃烧热(KJ/mol,定压):4060.9

21.燃烧热(KJ/mol,定容):4035.2

22.比热容(KJ/(kg·K) ,15~64ºC,定压):2.05

23.热导率(W/(m·K),液体):0.1845

24.热导率(W/(m·K),20ºC):0.1586

25.电导率(S/m,25ºC):3.792×10-7

安全信息

外观与性状:
淡黄色至淡琥珀色液体
密度:
1.004 g/mL at 25 °C(lit.)
熔点:
-23 °C
沸点:
199-200 °C(lit.)
闪点:
185 °F
水溶解性:
1.5 g/100 mL (25 ºC)
折射率:
n20/D 1.572(lit.)
蒸汽密度:
3.7 (vs air)
存储条件/存储方法:
库房通风低温干燥,与酸类和氧化剂分开存放
稳定性相关:

1.化学性质:与苯胺相似。与酸生成盐。与亚硝酸发生重氮化反应,生成重氮化合物。与醇、卤代烃、烯烃等反应,生成N-烷基化合物。在芳核上能发生烷基化、卤化、磺化、硝化、亚硝化等反应,发生在氨基的邻位和对位。与粉末状硫加热到200 ℃生成噻唑环。在稀硫酸中用铬酸、二氧化锰氧化时,根据条件不同,生成对甲苯醌、2,2'-二甲基偶氮苯或邻硝基甲苯等。用锂还原时得到2-甲基环己胺。

2.稳定性[22] 稳定

3.禁配物[23] 强氧化剂、酸类、酰基氯、酸酐、氯仿

4.避免接触的条件[24] 光照、受热

5.聚合危害[25] 不聚合

6.分解产物[26]

其它信息:

1.性状:无色或淡黄色油状液体[1]

2.熔点(℃):-16.3[2]

3.沸点(℃):200.3[3]

4.相对密度(水=1):1.008[4]

5.相对蒸气密度(空气=1):3.69[5]

6.饱和蒸气压(kPa):0.0346(25℃)[6]

7.燃烧热(kJ/mol):-4054.3[7]

8.临界压力(MPa):3.75[8]

9.辛醇/水分配系数:1.32[9]

10.闪点(℃):85(CC)[10]

11.引燃温度(℃):481.67[11]

12.爆炸上限(%):7.6[12]

13.爆炸下限(%):1.5[13]

14.溶解性:微溶于水,溶于乙醇、乙醚、稀酸。[14]

15.黏度(mPa·s,15ºC):5.195

16.黏度(mPa·s,25ºC):3.390

17.蒸发热(KJ/kg,b.p.):416.4

18.熔化热(KJ/kg):70.3

19.生成热(KJ/mol):-2.76

20.燃烧热(KJ/mol,定压):4060.9

21.燃烧热(KJ/mol,定容):4035.2

22.比热容(KJ/(kg·K) ,15~64ºC,定压):2.05

23.热导率(W/(m·K),液体):0.1845

24.热导率(W/(m·K),20ºC):0.1586

25.电导率(S/m,25ºC):3.792×10-7

毒理性

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XU2975000
CHEMICAL NAME :
o-Toluidine
CAS REGISTRY NUMBER :
95-53-4
LAST UPDATED :
199712
DATA ITEMS CITED :
99
MOLECULAR FORMULA :
C7-H9-N
MOLECULAR WEIGHT :
107.17
WISWESSER LINE NOTATION :
ZR B1

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
Open irritation test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
Standard Draize test
ROUTE OF EXPOSURE :
Administration into the eye
SPECIES OBSERVED :
Rodent - rabbit
TYPE OF TEST :
TCLo - Lowest published toxic concentration
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
25 mg/m3
TOXIC EFFECTS :
Kidney, Ureter, Bladder - urine volume increased Kidney, Ureter, Bladder - hematuria Blood - methemoglobinemia-carboxyhemoglobin
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
670 mg/kg
TOXIC EFFECTS :
Blood - normocytic anemia Blood - pigmented or nucleated red blood cells Blood - methemoglobinemia-carboxyhemoglobin
TYPE OF TEST :
LC50 - Lethal concentration, 50 percent kill
ROUTE OF EXPOSURE :
Inhalation
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
862 ppm/4H
TOXIC EFFECTS :
Behavioral - somnolence (general depressed activity) Behavioral - tremor Lungs, Thorax, or Respiration - cyanosis
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
520 mg/kg
TOXIC EFFECTS :
Blood - normocytic anemia Blood - pigmented or nucleated red blood cells Blood - methemoglobinemia-carboxyhemoglobin
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intraperitoneal
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - cat
DOSE/DURATION :
150 mg/kg
TOXIC EFFECTS :
Behavioral - coma Lungs, Thorax, or Respiration - dyspnea Blood - methemoglobinemia-carboxyhemoglobin
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
840 mg/kg
TOXIC EFFECTS :
Blood - normocytic anemia Blood - pigmented or nucleated red blood cells Blood - methemoglobinemia-carboxyhemoglobin
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Administration onto the skin
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
3250 uL/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Amphibian - frog
DOSE/DURATION :
151 mg/kg
TOXIC EFFECTS :
Behavioral - coma Lungs, Thorax, or Respiration - dyspnea Blood - methemoglobinemia-carboxyhemoglobin
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Mammal - species unspecified
DOSE/DURATION :
1700 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1125 mg/kg/5D-C
TOXIC EFFECTS :
Blood - changes in spleen Nutritional and Gross Metabolic - weight loss or decreased weight gain Related to Chronic Data - death
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
10200 mg/kg/30D-I
TOXIC EFFECTS :
Kidney, Ureter, Bladder - proteinuria Blood - normocytic anemia Nutritional and Gross Metabolic - weight loss or decreased weight gain
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
109 gm/kg/2Y-C
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Blood - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
320 mg/kg female 15-21 day(s) after conception
TOXIC EFFECTS :
Tumorigenic - neoplastic by RTECS criteria Lungs, Thorax, or Respiration - tumors Reproductive - Tumorigenic effects - transplacental tumorigenesis
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - rabbit
DOSE/DURATION :
840 mg/kg/14W-I
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
7250 mg/kg/23W-C
TOXIC EFFECTS :
Tumorigenic - equivocal tumorigenic agent by RTECS criteria Kidney, Ureter, Bladder - tumors
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
9520 mg/kg
SEX/DURATION :
male 17 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Paternal Effects - spermatogenesis (incl. genetic material, sperm morphology, motility, and count) Reproductive - Effects on Newborn - physical
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
9520 mg/kg
SEX/DURATION :
female 17 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - menstrual cycle changes or disorders Reproductive - Effects on Newborn - growth statistics (e.g.%, reduced weight gain) Reproductive - Effects on Newborn - physical
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Administration onto the skin
DOSE :
952 mg/kg
SEX/DURATION :
female 17 week(s) pre-mating
TOXIC EFFECTS :
Reproductive - Maternal Effects - ovaries, fallopian tubes Reproductive - Maternal Effects - menstrual cycle changes or disorders
TYPE OF TEST :
Specific locus test
TYPE OF TEST :
Micronucleus test
TYPE OF TEST :
DNA damage
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
DNA inhibition
TYPE OF TEST :
Sister chromatid exchange
TYPE OF TEST :
Sister chromatid exchange

MUTATION DATA

TYPE OF TEST :
Sex chromosome loss and nondisjunction
TEST SYSTEM :
Rodent - hamster Liver
REFERENCE :
PMRSDJ Progress in Mutation Research. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1981- Volume(issue)/page/year: 5,397,1985 *** REVIEWS *** ACGIH TLV-Animal carcinogen DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 ACGIH TLV-TWA 8.8 mg/m3 (2 ppm) (skin) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: TLV/BEI,1997 IARC Cancer Review:Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 16,349,1978 IARC Cancer Review:Human Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972- Volume(issue)/page/year: 27,155,1982 IARC Cancer Review:Group 2B IMSUDL IARC Monographs, Supplement. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) No.1- 1979- Volume(issue)/page/year: 7,362,1987 *** U.S. STANDARDS AND REGULATIONS *** MSHA STANDARD-air:TWA 5 ppm (22 mg/m3) DTLVS* The Threshold Limit Values (TLVs) and Biological Exposure Indices (BEIs) booklet issues by American Conference of Governmental Industrial Hygienists (ACGIH), Cincinnati, OH, 1996 Volume(issue)/page/year: 3,261,1971 OSHA PEL (Gen Indu):8H TWA 5 ppm (22 mg/m3) (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1910.1000,1994 OSHA PEL (Construc):8H TWA 5 ppm (22 mg/m3) (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1926.55,1994 OSHA PEL (Shipyard):8H TWA 5 ppm (22 mg/m3) (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 29,1915.1000,1993 OSHA PEL (Fed Cont):8H TWA 5 ppm (22 mg/m3) (skin) CFRGBR Code of Federal Regulations. (U.S. Government Printing Office, Supt. of Documents, Washington, DC 20402) Volume(issue)/page/year: 41,50-204.50,1994 *** OCCUPATIONAL EXPOSURE LIMITS *** OEL-AUSTRALIA:TWA 2 ppm (9 mg/m3);Skin;Carcinogen JAN 1993 OEL-BELGIUM:TWA 2 ppm (8.8 mg/m3);Skin;Carcinogen JAN 1993 OEL-DENMARK:TWA 2 ppm (9 mg/m3);Skin;Carcinogen JAN 1993 OEL-FINLAND:TWA 5 ppm (22 mg/m3);STEL 10 ppm (44 mg/m3);Skin;Carcinogen JAN 1993 OEL-FRANCE:TWA 2 ppm (9 mg/m3);Carcinogen JAN 1993 OEL-FRANCE;Carcinogen (salts) JAN 1993 OEL-GERMANY;Skin;Carcinogen JAN 1993 OEL-THE PHILIPPINES:TWA 5 ppm (22 mg/m3);Skin JAN 1993 OEL-POLAND:TWA 3 mg/m3 JAN 1993 OEL-RUSSIA:TWA 0.5 mg/m3;STEL 1 mg/m3;Skin;Carcinogen JAN 1993 OEL-SWEDEN;Carcinogen JAN 1993 OEL-SWITZERLAND:TWA 2 ppm (9 mg/m3);Skin;Carcinogen JAN 1993 OEL-TURKEY:TWA 5 ppm (22 mg/m3);Skin JAN 1993 OEL-UNITED KINGDOM:TWA 2 ppm (9 mg/m3);STEL 5 ppm (22 mg/m3) JAN 1993 OEL IN BULGARIA, COLOMBIA, JORDAN, KOREA check ACGIH TLV OEL IN NEW ZEALAND, SINGAPORE, VIETNAM check ACGIH TLV *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA ***NIOSH RECOMMENDED EXPOSURE LEVEL (REL) : NIOSH REL TO o-TOLUIDINE-air:CA lowest feasible concentration (Sk)REFERENCE : NIOSH* National Institute for Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda. Volume(issue)/page/year: DHHS #92-100,1992NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 73470 No. of Facilities: 2912 (estimated) No. of Industries: 21 No. of Occupations: 20 No. of Employees: 13053 (estimated) NOES - National Occupational Exposure Survey (1983) NOES Hazard Code - 73470 No. of Facilities: 2517 (estimated) No. of Industries: 32 No. of Occupations: 25 No. of Employees: 30019 (estimated) No. of Female Employees: 15501 (estimated)
毒理学数据:

1、急性毒性:大鼠经口LD50:940mg/kg;兔经皮LD50:3250mg/kg。

2、邻甲苯胺生成的高铁血红蛋白,引起神经障碍的作用很强,并能直接刺激膀胱,引起严重的膀胱炎、膀胱出血和血尿。本品能因皮肤吸收而中毒,应避免与皮肤接触。TJ 36—79规定车间空气中最高容许浓度为5mg/m3。

3.急性毒性[15]

LD50:670mg/kg(大鼠经口);3250ul(3250mg)/kg(兔经皮)

LC50:862ppm(大鼠吸入,4h)

4.刺激性[16]

家兔经皮:500mg(24h),轻度刺激。

家兔经眼:750μg(24h),重度刺激。

5.致突变性[17] 微生物致突变性:鼠伤寒沙门菌40μg/皿。微核试验:人淋巴细胞2mmol/L。程序外DNA合成:人HeLa细胞50μL/L。DNA抑制:人HeLa细胞50μL/L。姐妹染色单体交换:人淋巴细胞200μmol/L。哺乳动物体细胞突变:人淋巴细胞450mg/L。

6.致癌性[18] IARC致癌性评论:G2A,可能人类致癌物。

生态数据:

1.生态毒性[19]

LC50:100mg/L(96h)(鱼)

EC50:8mg/L(48h)(水蚤)

IC50:0.31~6.3mg/L(72h)(藻类)

2.生物降解性[20]

好氧生物降解(h):24~168

厌氧生物降解(h):96~672

3.非生物降解性[21]

光解最大光吸收(nm):234~284

光解最大光吸收波长范围(nm):62.4~3480

空气中光氧化半衰期(h):0.394~3.94

MSDS

国标编号: 61750
CAS: 95-53-4
中文名称: 2-甲基苯胺
英文名称: 2-Toluidine;o-Toluidine
别 名: 邻甲苯胺;2-氨基甲苯;邻氨基甲苯
分子式: C7H9N;CH3C6H4NH2
分子量: 107.15
熔 点: -24.4℃ 沸点:199.7?
密 度: 相对密度(水=1)1.00;
蒸汽压: 85℃
溶解性: 微溶于水,溶于乙醇、乙醚、稀酸
稳定性: 稳定
外观与性状: 无色或淡黄色油状液体
危险标记: 14(毒害品)
用 途: 用作染料中间体、有机合成及合成糖精等

2.对环境的影响:
一、健康危害
侵入途径:吸入、食入、经皮吸收。
健康危害:本品是强烈的高铁血红蛋白形成剂,并能刺激膀胱尿道,能致血尿。
急性中毒:多由皮肤污染而吸收。引起自觉脸部灼热、剧烈头痛、头晕、呼吸困难,呈现紫绀症。以后出现血尿、尿闭、精神障碍、肌肉抽搐。
慢性中毒:可引起膀胱刺激症状。
二、毒理学资料及环境行为
急性毒性:LD50670mg/kg(大鼠经口);3250mg/kg(兔经皮);人吸入176mg/m3×60分钟,严重毒作用;人吸入44mg/m3,出现症状;人吸入22mg/m3,不悦感。
致突变性:微生物致突变性:鼠伤寒沙门氏菌阳性。
致癌性:小鼠经口最低中毒剂量(TDL0):870g/kg(7周,连续),致肿瘤阳性。大鼠经口最低中毒剂量(TDL0):8200mg/kg(24周,间歇),致肿瘤阳性。
危险特性:遇明火、高热或与氧化剂接触,有引起燃烧爆炸的危险。受高热分解放出有毒气体。
燃烧(分解)产物:一氧化碳、二氧化碳、氧化氮。
3.现场应急监测方法:
4.实验室监测方法:
对二甲氨基本甲醛比色法《空气中有害物质的测定方法》(第二版)杭士平主编
对硝基重氮苯比色法《空气中有害物质的测定方法》(第二版)杭士平主编
气相色谱法《空气中有害物质的测定方法》(第二版)杭士平主编
5.环境标准:
前苏联车间卫生标准3mg/m3
前苏联(1975)水体中有害物质最高允许浓度1.0mg/L
 空气中嗅觉阈浓度1.1ppm
6.应急处理处置方法:
一、泄漏应急处理
   疏散泄漏污染区人员至安全区,禁止无关人员进入污染区,建议应急处理人员戴好防毒面具,穿化学防护服。戴好防毒面具,穿一般消防防护服。合理通风,不要直接接触泄漏物,在确保安全情况下堵漏。喷雾状水,减少蒸发。用沙土或其它不燃性吸附剂混合吸收,然后收集运至废物处理场所处置。也可以用大量水冲洗,经稀释的洗水放入废水系统。如大量泄漏,利用围堤收容,然后收集、转移、回收或无害处理后废弃。
废弃物处置方法:建议用控制焚烧法处置。焚烧炉排出的氮氧化物通过洗涤器或高温装置除去。 
二、防护措施
呼吸系统防护:可能接触其蒸气时,佩带防毒面具。紧急事态抢救或逃生时,佩带正压自给式呼吸器。
眼睛防护:戴安全防护眼镜。
防护服:穿紧袖工作服,长统胶鞋。
手防护:戴橡皮手套。
其它:工作现场禁止吸烟、进食和饮水。及时换洗工作服。工作前后不饮酒,用温水洗澡。监测毒物。进行就业前和定期的体检。
三、急救措施
皮肤接触:立即脱去污染的衣着,用肥皂水及清水彻底冲洗。注意手、足和指甲等部位。
眼睛接触:立即提起眼睑,用大量流动清水或生理盐水冲洗。
吸入:迅速脱离现场至空气新鲜处。呼吸困难时给输氧。呼吸停止时,立即时进行人工呼吸。就医。
食入:误服者给漱口,饮水,洗胃后口服活性炭,再给以导泻。就医。
灭火方法:雾状水、泡沫、二氧化碳、干粉、砂土。

分子结构与计算化学数据

分子结构数据

1、摩尔折射率:35.31

2、摩尔体积(cm3/mol):107.9

3、等张比容(90.2K):270.7

4、表面张力(dyne/cm):39.5

5、极化率(10-24cm3):13.99

计算化学数据

1.疏水参数计算参考值(XlogP):无

2.氢键供体数量:1

3.氢键受体数量:1

4.可旋转化学键数量:0

5.互变异构体数量:无

6.拓扑分子极性表面积26

7.重原子数量:8

8.表面电荷:0

9.复杂度:70.8

10.同位素原子数量:0

11.确定原子立构中心数量:0

12.不确定原子立构中心数量:0

13.确定化学键立构中心数量:0

14.不确定化学键立构中心数量:0

15.共价键单元数量:1

热门化工词典词汇